Effect of antipyrine coadministration on the kinetics of acetaminophen and lidocaine
- 1 January 1988
- journal article
- research article
- Published by Springer Nature in European Journal of Clinical Pharmacology
- Vol. 35 (4) , 413-417
- https://doi.org/10.1007/bf00561374
Abstract
Pharmacokinetic interactions between antipyrine and acetaminophen were evaluated in 7 healthy volunteers. On 3 occasions subjects received:1, antipyrine 1.0 g intravenously (i.v.);2, acetaminophen 650 mg i.v.;3, antipyrine 1.0 g and acetaminophen 650 mg i.v. simultaneously. Between Trials 1 and 3, antipyrine elimination t1/2 (17.2 vs 17.4 h), clearance (0.44 vs 0.43 ml·min−1·kg−1) and 24-h recovery of antipyrine and metabolites (313 vs 293 mg) did not differ significantly. Between Trials 2 and 3, acetaminophen Vz was reduced (1.14 vs 1.00 l·kg−1), t1/2 prolonged (2.7 vs 3.3 h), clearance reduced (4.8 vs 3.6 ml·min−1·kg−1), and fractional urinary recovery of acetaminophen glucuronide reduced. Eight additional subjects received 50 mg of lidocaine hydrochloride i.v. in the control state, and on a second occasion immediately after antipyrine 1.0 g given i.v. The two trials did not differ significantly in lidocaine Vz (2.6 vs 2.7 l·kg−1), t1/2 (2.0 vs 2.4 h) or clearance (15.0 vs 13.5 ml·min−1·kg−1). Although acetaminophen does not alter antipyrine kinetics, acute administration of antipyrine appears to impair acetaminophen clearance, possibly via inhibition of glucuronide formation. However, antipyrine has no significant effect on the kinetics of a single i.v. dose of lidocaine.This publication has 35 references indexed in Scilit:
- Large Theophylline Requirements due to High Theophylline Clearance: Verification by the Antipyrine TestPharmacology, 1986
- Monogenic control of variations in antipyrine metabolite formation. New polymorphism of hepatic drug oxidation.Journal of Clinical Investigation, 1983
- Assessment of Methods to Identify Sources of Interindividual Pharmacokinetic VariationsClinical Pharmacokinetics, 1983
- Interindividual Variations in Drug DispositionClinical Pharmacokinetics, 1983
- Drugs as Indicators of Hepatic FunctionHepatology, 1982
- Clinical Pharmacokinetics of ParacetamolClinical Pharmacokinetics, 1982
- Reduction in Lidocaine Clearance during Continuous Infusion and by Coadministration of PropranololNew England Journal of Medicine, 1980
- Lidocaine Kinetics Predicted by Indocyanine Green ClearanceNew England Journal of Medicine, 1978
- Clinical Pharmacokinetics of LignocaineClinical Pharmacokinetics, 1978
- Factors influencing antipyrine elimination.British Journal of Clinical Pharmacology, 1977